Women’s Health Report Assesses first-in-class innovation with focus on endometriosis, polycystic ovarian syndrome and cervical intraepithelial neoplasia

This report assesses first-in-class innovation across the women’s health therapy area, with a particular focus on three key indications: endometriosis, polycystic ovarian syndrome (PCOS) and cervical intraepithelial neoplasia (CIN).

Pune, India - March 14, 2018 /MarketersMedia/ —

The women’s health therapy area covers medical disorders that affect females only, primarily disorders of the female reproductive system, including those associated with menstruation, conception, pregnancy, childbirth and menopause. Many of these disorders are highly prevalent among the female population. Despite this, the women’s health market is relatively small. This reflects diagnostic barriers and high levels of non-treatment for women’s health disorders, as well as high levels of genericization and relatively limited innovation within recent decades.
Access Report Details at: https://www.themarketreports.com/report/frontier-pharma-womens-health-an-expanding-therapy-area-with-endometriosis-therapies-prominent-among-the-first-in-class-pipeline
Scope
• Many women’s health disorders are highly prevalent. How do epidemiology trends vary for endometriosis, PCOS and CIN?
• Innovation within women’s health has been relatively limited over recent decades. What are the most prominent unmet needs across this therapy area?
• There are 261 pipeline programs in active development for women’s health. What proportion of these products are first-in-class? How does first-in-class innovation vary by indication, development stage and molecular target class?
• Although the first-in-class pipeline is relatively modest in size it is considerably diverse with eight distinct molecular target classes represented. Which first-in-class targets have been identified as most promising for women’s health conditions?
• Over 200 licensing deals relating to women’s health have been completed since 2006. Do women’s health products typically attract high deal values? Which first-in-class products have prior deal involvement?
Inquire for more details at: https://www.themarketreports.com/report/ask-your-query/987871
Reasons To Buy
• Understand the current clinical and commercial landscape. This includes a comprehensive study of symptoms, epidemiology, etiology, pathophysiology, co-morbidities and complications, diagnosis and treatment options.
• Visualize the composition of the women’s health market in terms of dominant molecule types and molecular targets, highlighting what the current unmet needs are and how they can be addressed. This knowledge allows a competitive understanding of gaps in the current market.
• Analyze the women’s health pipeline and stratify by stage of development, molecule type and molecular target.
• Assess the therapeutic potential of first-in-class targets. Using a proprietary matrix, first-in-class products have been assessed and ranked according to clinical potential. Promising first-in-class targets have been reviewed in greater detail.
• Recognize commercial opportunities in the women’s health deals landscape by analyzing trends in licensing and co-development deals, and identifying women’s health therapies that have not yet been involved in deals and may offer potential investment opportunities.
Get this report at: https://www.themarketreports.com/report/buy-now/987871

Contact Info:
Name: Shirish Gupta
Email: sales@themarketreports.com
Organization: The Market Reports
Address: SF-29, Sacred World, Wanawadi
Phone: 16314071315

Source URL: https://marketersmedia.com/womens-health-report-assesses-first-in-class-innovation-with-focus-on-endometriosis-polycystic-ovarian-syndrome-and-cervical-intraepithelial-neoplasia/314337

For more information, please visit https://www.themarketreports.com/report/frontier-pharma-womens-health-an-expanding-therapy-area-with-endometriosis-therapies-prominent-among-the-first-in-class-pipeline%20%20

Source: MarketersMedia

Release ID: 314337

Latest News

Asian shares slip on trade worries, oil gives up some gains

Jun 25, 2018

By Hideyuki SanoTOKYO (Reuters) - Asian shares fell on Monday on escalating trade tensions between the United States and major economies while oil prices gave up some of their hefty gains made after major oil producers agreed to a modest increase in production.S&P500 mini futures eased as much as 0.6 percent in early trade while MSCI's broadest index of Asia-Pacific shares outside Japan fell 0.25 percent. Japan's Nikkei lost 0.4 percent.The falls were triggered by a report from the Wall Street Journal that U.S. President Donald Trump plans to bar many Chinese companies from investing in U.S. technology firms and...

NZ central bank set to keep low rates as growth slows, trade woes cloud outlook

Jun 25, 2018

By Leika KiharaWELLINGTON (Reuters) - New Zealand's central bank is set to keep interest rates on hold this week and signal that no monetary tightening is on the cards in the near-term, with inflation subdued and escalating global trade friction clouding the outlook for an already slowing economy.All 16 economists polled by Reuters expect the Reserve Bank of New Zealand (RBNZ) to hold rates at 1.75 percent at its rate review on Thursday.Markets are on the lookout for any tweak governor Adrian Orr - who took on the job in March with a pledge to simplify the RBNZ's communication -...

Buoyant euro keeps dollar off 11-month highs, trade issues in focus

Jun 25, 2018

By Shinichi SaoshiroTOKYO (Reuters) - The buoyant euro kept the dollar from hitting an 11-month high on Monday, with trade issues between the United States and the European Union seen deciding the near-term direction for the currencies.The euro was 0.05 percent higher at $1.1662 after gaining about 0.5 percent on Friday. The single currency was lifted after Friday's upbeat German and French business activity data and fresh assurances by Italian politicians that their nation would not leave the single currency.The dollar index against a basket of six major currencies stood at 94.515 having retreated from 95.529, its highest level since...

New Zealand leader leaves hospital 3 days after giving birth

Jun 25, 2018

WELLINGTON, New Zealand — New Zealand Prime Minister Jacinda Ardern and her partner have named their baby daughter Neve and say they want her to grow up in a world in which she can make choices about her family and career based on what she wants. Ardern made her first public appearance on Sunday since giving birth to her daughter on Thursday. She answered a few questions from reporters while holding her baby at Auckland City Hospital before she planned on returning home. She will take six weeks of leave before returning to work. Ardern is just the second elected...

Against the grain: Australian banks face rural lending reckoning

Jun 25, 2018

By Byron KayeSYDNEY (Reuters) - Australian potato farmer Tom Fox says he had never missed a bank payment in two decades before a delay sending a shipment to Indonesia during a trade dispute between the countries prompted his lender to force him into receivership in 2013."I got a letter from the bank lawyers saying I had 12 hours to come up with A$2.4 million ($1.8 million), and that was an impossibility to do on that notice," Fox told Reuters.A third-generation farmer who built up the country's biggest seed potato producer, Fox said his farm and equipment were sold below value...

Stock Markets

About Us

The Morning Herald is a fast news provider in the United States since 2005. Fiercely independent and armed with irreverent intelligence, there’s no other place to get your news other than The Morning Herald.

Contact us: sales[at]themorningherald.com

Subscribe Now!